Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam E Mullick

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Investigation|June 15, 2021
Eruptive xanthoma model reveals endothelial cells internalize and metabolize chylomicrons, leading to extravascular triglyceride accumulationAinara G Cabodevilla, Songtao Tang, Sungwoon Lee, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 26, 2018
Mechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) InhibitionDebapriya Basu, Lesley-Ann Huggins, Diego Scerbo, et al.
Circulation Research|July 9, 2021
Loss of Hepatic Angiotensinogen Attenuates Sepsis-Induced Myocardial DysfunctionJiabing Rong, Xinran Tao, Yao Lin, et al.
Global Translational Medicine|June 9, 2023
Antisense oligonucleotides targeting hepatic angiotensinogen reduce atherosclerosis and liver steatosis in hypercholesterolemic miceDien Ye, Congqing Wu, Lei Cai, et al.
JCI Insight|June 2, 2022
Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling by triglyceride loweringBastian Ramms, Sohan Patel, Xiaoli Sun, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
Antisense Oligonucleotide Targeting Hepatic Serum Amyloid A Limits the Progression of Angiotensin II-Induced Abdominal Aortic Aneurysm FormationPreetha Shridas, Ailing Ji, Andrea C Trumbauer, et al.
Atherosclerosis|March 10, 2024
Antisense oligonucleotide targeting hepatic Serum Amyloid A limits the progression of angiotensin II-induced abdominal aortic aneurysm formationPreetha Shridas, Ailing Ji, Andrea C Trumbauer, et al.
Journal of the American College of Cardiology|April 9, 2011
Antisense oligonucleotide lowers plasma levels of apolipoprotein (a) and lipoprotein (a) in transgenic miceEsther Merki, Mark Graham, Adam Taleb, et al.
Nature Immunology|February 13, 2023
Apolipoprotein C3 induces inflammasome activation only in its delipidated formCheng-Chieh Hsu, Baohai Shao, Jenny E Kanter, et al.
Antioxidants (Basel, Switzerland)|January 28, 2026
Targeting Arginase 1 but Not Arginase 2 Protects from Myocardial Ischemia-Reperfusion Injury via Nitric Oxide Signaling by Red Blood Cells in Type 2 DiabetesJiangning Yang, Yahor Tratsiakovich, Renhai Cao, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Investigation|June 15, 2021
Eruptive xanthoma model reveals endothelial cells internalize and metabolize chylomicrons, leading to extravascular triglyceride accumulationAinara G Cabodevilla, Songtao Tang, Sungwoon Lee, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 26, 2018
Mechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) InhibitionDebapriya Basu, Lesley-Ann Huggins, Diego Scerbo, et al.
Circulation Research|July 9, 2021
Loss of Hepatic Angiotensinogen Attenuates Sepsis-Induced Myocardial DysfunctionJiabing Rong, Xinran Tao, Yao Lin, et al.
Global Translational Medicine|June 9, 2023
Antisense oligonucleotides targeting hepatic angiotensinogen reduce atherosclerosis and liver steatosis in hypercholesterolemic miceDien Ye, Congqing Wu, Lei Cai, et al.
JCI Insight|June 2, 2022
Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling by triglyceride loweringBastian Ramms, Sohan Patel, Xiaoli Sun, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
Antisense Oligonucleotide Targeting Hepatic Serum Amyloid A Limits the Progression of Angiotensin II-Induced Abdominal Aortic Aneurysm FormationPreetha Shridas, Ailing Ji, Andrea C Trumbauer, et al.
Atherosclerosis|March 10, 2024
Antisense oligonucleotide targeting hepatic Serum Amyloid A limits the progression of angiotensin II-induced abdominal aortic aneurysm formationPreetha Shridas, Ailing Ji, Andrea C Trumbauer, et al.
Journal of the American College of Cardiology|April 9, 2011
Antisense oligonucleotide lowers plasma levels of apolipoprotein (a) and lipoprotein (a) in transgenic miceEsther Merki, Mark Graham, Adam Taleb, et al.
Nature Immunology|February 13, 2023
Apolipoprotein C3 induces inflammasome activation only in its delipidated formCheng-Chieh Hsu, Baohai Shao, Jenny E Kanter, et al.
Antioxidants (Basel, Switzerland)|January 28, 2026
Targeting Arginase 1 but Not Arginase 2 Protects from Myocardial Ischemia-Reperfusion Injury via Nitric Oxide Signaling by Red Blood Cells in Type 2 DiabetesJiangning Yang, Yahor Tratsiakovich, Renhai Cao, et al.
Pageof 9